Repros Therapeutics Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (38)

View All

Latest Posts

About This Stock More About This Stock
How Risky Is Royalty Pharma’s Dividend?
Article By: Marc Lichtenfeld
Wednesday, February 7, 2024 9:40 PM EDT
Royalty Pharma just announced a 5% dividend increase, its fourth raise in a row. It has boosted the dividend every year since it began paying one in 2020. The new $0.21 per share quarterly dividend gives the stock a 3% yield
In this article: RPRX
Read
Warren Buffett Stocks: Royalty Pharma Plc
Article By: SureDividend
Friday, July 8, 2022 5:22 PM EDT
As of March 31st, 2022, Buffett’s Berkshire Hathaway owned about 1.5 million shares of Royalty Pharma plc for a market value of $58.3 million. Let's analyze the healthcare company in greater detail.
In this article: RPRX Also: BRK-B
Read
Notable Insider Buys: Continental Resources, Fox, Groupon And More
Article By: Benzinga
Saturday, June 27, 2020 7:24 PM EDT
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit. So insider buying can be an encouraging signal for potential investors.
In this article: CLR, ED, CATM, RPRX, GRPN, WSBC, EPZM, FOX, VST
Read
Royalty Pharma Jumps Over 50% In Largest IPO Of 2020
Article By: The Fly
Sunday, June 21, 2020 2:36 PM EDT
Shares of Royalty Pharma jumped over 50% above their initial public offering price of $28 on Tuesday, June 16, in the biggest IPO to date in 2020.
In this article: RPRX
Read
Repros Announces Pricing Of $3.0 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, May 18, 2017 3:12 PM EDT
Repros Therapeutics Inc., announced today that it has entered into an underwriting agreement to sell in a public offering 2,744,125 shares of the Company’s common stock.
In this article: RPRX
Read
All Posts

Latest Tweets for $RPRX

No tweets yet!

PARTNER HEADLINES